Table of Contents
Main Features
Distinguishing Features
Differential Dx
Pathogenesis
Treatment
Resources
Leber Congenital Amaurosis
First described in 1869 by Theodore Leber.
Main Features
Congenital or Early infancy non-syndromic retinal blindness
Searching nystagmus
Abnormal pupil reponses
“oculodigital sign”- digital eye pressure to induce retinal response
Fundus appearance:
Initially can have normal fundus appearance followed by pigmentary changes in the retina, vascular attenuation and optic nerve pallor.
Bone spicules in macula and periphery
Loss of retinal lamination and photoreceptor loss
Exudative type retinopathy in CRB1-assoicated disease
RPE65-related disease usually has milder peripheral RPE mottling and white dots
Disc drusen or pseudopapilledema
Distinguishing Features
Severe visual impairment from birth or first few months of life
Fundus appearance
may be normal
Vessel attenuation, disc pallor, peripheral retinal pigmentation
ERG is undetectable
Differential Dx
Achromatopsia
Congenital Stationary Night Blindness
Retinitis Pigmentosa
Idiopathic Nystagmus Syndrome
Pathogenesis
70% of patients have a known genetic variant io one of the following genes that preferentially are expressed in the retina or RPE
Autosomal Recessive
AIPL1, ALMS1, CEP290, CRB1 (photoreceptor cell structure), GUCY2D (Protein trafficking), IMPDH1, LCA5, LRAT (visual cycle function), MERTK, RD3 ,RDH12, RPGRIP1, RPE65 (visual cycle function), SPATA7, KCNJ13, ICQB1, NMNAT1, and TULP1
Autosomal Dominant: CRX - photoreceptor cell development
Treatment
RPE65 Mutations
Gene replacement therapy with
Luxturna
(vortigene neparvovec-rzyl)
Adeno-associated virus vector administered subretinally
Resources
Taylor and Hoyt chapter 46. Leger congenital amaurosis.
inherited retinal disease
,
retina